Hepatitis C virus infection in two groups of paediatric patients: One maintained on haemodialysis and the other on continuous ambulatory peritoneal dialysis

Annals of Tropical Paediatrics

Volumn 16, Issue 4, 1996, Pages 335-339

  Al Mugeiren, M ^a   Al Rasheed, S ^a   Al Salloum, A ^a   El Zouki, A ^b   Al Sohaibani, M ^a   Al Fawaz, I ^a   Ramia, S ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b Maternity and Children's Hospital   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY;

ADOLESCENT; ANTIBODY TITER; ARTICLE; CHILD; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; HEMODIALYSIS; HEPATITIS C; HUMAN; MALE; SERODIAGNOSIS; VIRUS TRANSMISSION;

EID: 0029853677     PISSN: 02724936     EISSN: None     Source Type: Journal    
DOI: 10.1080/02724936.1996.11747846     Document Type: Article

References (18)

1. Choo QL, Weiner AJ, Overby LR, Kuo G, Houghton M, Bradley DW. Hepatitis C virus: The major causative agent of viral non-A, non-B hepatitis. Br Med Bull 1990; 46:423-41.
2. Choo QL, Richman KH, Han JM, et al. Genetic organization and diversity of hepatitis C virus. Proc Natl Acad Sci USA 1991; 88:2451-5.
3. Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244:362-4.
4. Bahakim H, Bakir TM, Arif M, Ramia S. Hepatitis C virus antibodies in high risk Saudi groups. Vox Sang 1991; 60:162-4.
5. Alter HJ. New kit on the block: evaluation of second generation assays for the detection of antibody to the hepatitis C virus. Hepatology 1992; 15:229-33.
6. Ramia S. Hepatitis C virus: molecular virology and its implication for serologic diagnosis. Saudi J Kidney Dis Transplant 1995; 6:190-6.
7. Wonbe B, Hoffbrand AV, Brown D, Dusheiko G. Antibody to hepatitis C virus in multiple transfused patients with thalassemia major. J Clin Pathol 1990; 43:638-40.
8. Esteban JI, Esteban R, Viladomiu L, et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989; 2:294-7.
9. Ayoola EA, Huraib S, Arif M, et al. The prevalence and significance of antibodies to hepatitis C virus among Saudi hemodialysis patients. J Med Virol 1991; 35:155-9.
10. Al-Mugeiren M, Al-Faleh FZ, Ramia S, Al-Rasheed S, Mahmoud MA, Al-Nasser M. Seropositivity to hepatitis C virus (HCV) in Saudi children with chronic renal failure maintained on haemodialysis. Ann Trop Paediatr 1992; 12:217-19.
11. Al-Faleh FZ, Ayoola EA, Al-Jeffry M, et al. Prevalence of antibody to hepatitis C virus among Saudi Arabian children: A community based study. Hepatology 1991; 14:215-18.
12. Zaauer HL, Vrielink H, van Exel-Oehlers PJ, Cuypero HIM, Lelie PN. Confirmation of hepatitis C infection: a comparison of five immunoblot assays. Transfusion 1994; 34:603-7.
13. Popovich RP, Moncrief JW, Nolph KD, Ghods AJ, Twardowski ZJ, Pyle WK. Continuous ambulatory peritoneal dialysis. Ann Int Med 1978; 88:449-56.
14. Gokal R, Worldwide experience, cost effectiveness and future of CAPD - its role in renal replacement therapy. In: Gokal R ed. Continuous Ambulatory Peritoneal Dialysis. Edinburgh: Churchill Livingstone, 1986; 249-369.
15. Donahue JG, Munoz A, Ness PM, et al. The decline risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992; 327:369-73.
16. Favero MS. Recommended precautions for patients undergoing hemodialysis who have AIDS or non-A, non-B hepatitis. Infect Control 1985; 6:301-5.
17. Gladziwa U, Schlipköter Lorbeer B, Cholmakow K, Roggendorf M, Sieberth HG. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis - a multicenter study. Clin Nephrol 1993; 40:46-52.
18. Caramelo C, Navas S, Alberola ML, Bermejillo T, Reyero A, Carreṅo V. Evidence against transmission of hepatitis C virus through hemodialysis ultrafiltrate and peritoneal fluid. Nephron 1994; 66:470-3.